Oncopeptides completes IPO

On Feb. 22, cancer company Oncopeptides AB (SSE:ONCO) raised SEK650 million ($72.7 million) through the sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Inv...